The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Olaparib-induced severe folate deficiency in women with relapsed ovarian cancer: First report and case series.
 
Jamile M. Shammo
No Relationships to Disclose
 
Lydia Usha
Consulting or Advisory Role - Agendia; AstraZeneca; Myriad Pharmaceuticals
Travel, Accommodations, Expenses - AstraZeneca; Myriad Pharmaceuticals
 
Kristin J. Richardson
No Relationships to Disclose
 
Elizabeth Elliott
No Relationships to Disclose
 
Summer Dewdney
No Relationships to Disclose
 
Parameswaran Venugopal
Consulting or Advisory Role - Abbvie; Bayer
 
Melody A. Cobleigh
Consulting or Advisory Role - Roche
Research Funding - Cascadian Therapeutics; Macrogenics; Roche
Patents, Royalties, Other Intellectual Property - Genomic Health
Other Relationship - Puma Biotechnology; Roche
 
Timothy Kuzel
Honoraria - Abbvie; Amgen; Argos Therapeutics; Astellas Pharma; Bristol-Myers Squibb; Celgene; Eisai; Exelixis; Genentech/Roche; Medivation; Merck
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; CVS; Emmaus Medical INC.; Kyowa Hakko Kirin; Seagen; Stemline Therapeutics
Speakers' Bureau - Celgene; Genentech/Roche; Sanofi Pasteur
Research Funding - Bristol-Myers Squibb (Inst); Eisai (Inst); Genentech/Roche (Inst); Seagen
Travel, Accommodations, Expenses - Amgen; Argos Therapeutics; Celgene; Emmaus Medical INC.; Genentech; Kyowa Hakko Kirin; Merck; Seagen; Stemline Therapeutics